miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma - Test2 - elhamkhani - TriplyDB

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

http://www.wikidata.org/entity/Q34786575

about

The Role of MicroRNAS in Ankylosing Spondylitis miR-381 Regulates Neural Stem Cell Proliferation and Differentiation via Regulating Hes1 Expression Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1.Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor MTDH genetic variants in colorectal cancer patients.Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.MicroRNA-300 inhibited glioblastoma progression through ROCK1.Association of MTDH immunohistochemical expression with metastasis and prognosis in female reproduction malignancies: a systematic review and meta-analysis.Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.Tensor decomposition-based unsupervised feature extraction applied to matrix products for multi-view data processing.microRNA deregulation in keloids: an opportunity for clinical intervention?Mechanisms of miR-145 regulating invasion and metastasis of ovarian carcinoma.Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression.Role of microRNAs in primary central nervous system lymphomas.MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis.The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells.MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1 Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.Small RNA sequencing reveals a comprehensive miRNA signature of BRCA1-associated high-grade serous ovarian cancer.miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer.Cationic microRNA-delivering nanocarriers for efficient treatment of colon carcinoma in xenograft model.LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression MicroRNAs: new players in cataract.Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration.Upregulation of microRNA-18b induces phosphatase and tensin homolog to accelerate the migration and invasion abilities of ovarian cancer.MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer.Adipose Derived Stem Cells Affect miR-145 and p53 Expressions of Co-Cultured Hematopoietic Stem Cells.Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer.

P2860

Q26750680-DCB66DCC-5E94-4B6C-A972-24E2C29DB33B Q35796877-F4208146-E0F8-481E-9245-90FB369C63AB Q36213360-54D0F1FC-285E-4B8F-BC1B-13E891881F89 Q36248459-C812ABD7-F331-4A61-8A8B-3ABF5C6FBC24 Q36262119-BE244A1D-D837-407B-9CFD-EF7D84462427 Q36516593-0A53B738-9884-47D7-BF66-C5244710A917 Q36694223-53D3BE5A-286F-4643-86ED-A5D72591BE99 Q36738971-BB3D3968-B843-4514-85A0-E2BC30372F43 Q37144091-FABEB1FC-BBE2-42C0-9515-C38771D37163 Q37272622-93AA0DAC-490F-4D30-B1F7-0293B0B95390 Q37392761-C1B83C5C-B585-4227-BB33-BCBF67B3915C Q37471949-1AABE269-D6C3-44BB-8799-3BF37979407B Q37687781-1EF34D88-603D-43A7-9447-D9B4678301EA Q37697194-FE13BC2D-541C-47AA-9C3E-80108B05852C Q37699375-B9724F88-3D05-4098-BAFA-973A14A8BB25 Q38608064-BB3B03A4-A0F7-4BBB-8D74-48831F35C0C3 Q38612431-A39D21FD-06CB-415A-A66D-E9F448303AAB Q38643149-0C550EB3-17E1-4253-B056-74B4E6A09181 Q38670568-9AC65CF4-8DC8-4A2C-B889-15440EDB5DF8 Q38779730-6E8913A5-87AB-4990-9CC9-4BEA7E966CC4 Q38814833-B601788A-16F3-4B7D-886F-A2A7F4512248 Q38819843-D97AB054-98FF-4F28-8F2D-8D87CD47CDAC Q38850882-B85D6DEF-517C-4CE2-A59A-94131654367C Q38855230-75A3F1BE-1E8F-46E9-8460-1D4D883F1808 Q38897001-48609B8B-EE73-4F0F-8915-52FA37E86B7F Q38975570-D10B70C7-F9A6-40F7-AF98-5FAEBED5433C Q39303945-62D81119-A8F8-441F-903E-BBAE8056E739 Q39391417-CAF187F2-FD07-47F7-B0AF-DAB411FDF918 Q39860520-D5936ED9-B75C-4EB5-8D95-1D2266BC7B51 Q41549337-5D72479A-25B0-475C-B0A4-444F433C15AB Q41593179-C671CDFF-0E63-4FD0-B3B2-B200DDF3D47B Q41967527-2FD3C0EA-2C95-4682-8B6C-BEA230B9F32E Q42048438-15282CFB-D975-45D7-810C-6225E13F7EFC Q42068041-687A18AF-D71F-42BB-A5DB-FC5CF007021E Q42367908-4D5DC8BE-58E6-412A-A11E-B319629A6BC7 Q43907188-AF188E42-118E-43E4-B1F1-684589F29686 Q45986075-3A1F8CAE-A119-4877-987D-29F3817D64FC Q47138409-B2B94CC2-42BA-41F7-A39D-A445F39AD40E Q47654143-BB25CC21-01C5-4453-9B36-89030046DD41 Q48140189-6FFBB022-1F6E-4343-83B3-12653FCC700E

P2860

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

http://www.wikidata.org/entity/Q34786575

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@ast

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@en

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@nl

type

label

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@ast

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@en

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@nl

prefLabel

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@ast

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@en

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@nl

P1433

Q34786575-6C314F15-B0A2-41AD-9DAD-789ADE7E4AC1

P1476

Q34786575-C27CEAB1-C2F0-440C-AFD8-48AD034F624F

P2093

Q34786575-07F9191E-BD3E-4E31-BBC4-9CB75E4D668A

Q34786575-292C6206-5873-46DB-BB4A-A9DD09C49EE4

Q34786575-296425ED-B12E-42CE-A52D-5EE20D2BEAD6

Q34786575-38D92F01-7CF1-4426-A625-10988A129FA8

Q34786575-4E4E8643-94F2-4C76-9C22-37470C97E516

Q34786575-6BB901BF-1881-4BC1-9F98-E5DFBC86C3FC

Q34786575-7519C02B-016A-4E22-8D64-1ADD0F000D9E

Q34786575-75969858-2390-4FF4-BB48-C05B5EBE53EF

Q34786575-7D4BBFDE-233F-4D0F-87EB-1FD3EDFB39C8

Q34786575-7F03499C-EABE-48CE-B040-9F3F1FDD3300

P2860

Q34786575-041AC233-4BA2-42BC-9BAD-050EB510B331

Q34786575-165C67A2-8103-43A8-948F-F6C16D8FDBF7

Q34786575-19ACED12-4FE1-4C21-A094-99C39ADEE5D6

Q34786575-1CACB689-9534-4D0B-A74E-D71FFB8F6B0A

Q34786575-2A6DB415-4A8E-426D-8317-43747C40ED53

Q34786575-333E3900-A38E-4AFD-8740-3D35DD7274E9

Q34786575-343B60D7-6C6E-4FB4-9255-F3AC209902E6

Q34786575-36F80954-846C-4026-8694-573AA375F389

Q34786575-486F1507-F0CB-4922-A587-FDD89BBE2F35

Q34786575-50DB7BC6-9716-43F7-B5EA-2140A41F6FFB

P304

Q34786575-E709BFFF-4F25-4823-AB13-844F2E8AC20E

P31

Q34786575-A91ECAE1-F99B-4778-BDB1-1CF52F232356

P356

Q34786575-72399AB4-2832-453A-92B0-3303E4A1E08B

P407

Q34786575-39D1B1C2-93F8-478D-8482-1077704167E5

P433

Q34786575-0322C9EA-91B0-484A-99F7-6527C64B1837

P478

Q34786575-AA1CC971-0E33-4E23-9709-E157E8EB0B79

P577

Q34786575-62FFC260-6400-483A-97F0-C2EA3DF251C2

P5875

Q34786575-3A414900-D384-49AA-B252-1E20D8E13450

P698

Q34786575-4C2FCE44-46AE-4AAE-B564-C708BB24176B

P932

Q34786575-979FA253-7033-49D6-8A92-EE3E0C1ADEC3

P356

ONCOTARGET.2522

P1433

P1476

miR-145 inhibits tumor growth ...... grade serous ovarian carcinoma

@en

P2093

Beihua Kong

http://www.w3.org/2001/XMLSchema#string

Changshun Shao

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Wei

http://www.w3.org/2001/XMLSchema#string

Jinsong Liu

http://www.w3.org/2001/XMLSchema#string

Qifeng Yang

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Ruifen Dong

http://www.w3.org/2001/XMLSchema#string

Xiaolin Liu

http://www.w3.org/2001/XMLSchema#string

Yingwei Li

http://www.w3.org/2001/XMLSchema#string

Yinuo Li

http://www.w3.org/2001/XMLSchema#string

P2860

MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors

miR-145 and miR-143 regulate smooth muscle cell fate and plasticity

p53 represses c-Myc through induction of the tumor suppressor miR-145

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

Integrated genomic analyses of ovarian carcinoma

MicroRNA signatures in human ovarian cancer

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

Modulation of microRNA processing by p53

P304

10816-10829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2522

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267274234

http://www.w3.org/2001/XMLSchema#string

P698

25333261

http://www.w3.org/2001/XMLSchema#string

P932

4279412

http://www.w3.org/2001/XMLSchema#string